Diabetic Neuropathy Nursing Guide

Classification, assessment tools, foot care, Charcot arthropathy, pain management, and GCC-specific risks

Foot Care Critical Monofilament Test Pregabalin / Duloxetine Charcot Arthropathy

Epidemiology

  • Diabetic neuropathy affects approximately 50% of diabetics after 10 years of disease
  • Most common complication of diabetes mellitus
  • Leading cause of non-traumatic lower limb amputation worldwide
  • Risk increases with duration of diabetes, poor glycaemic control, hypertension, dyslipidaemia, smoking, and alcohol
  • Can affect any peripheral nerve, autonomic nerve, or cranial nerve

Classification of Diabetic Neuropathy

TypeCharacteristicsSymptoms
Distal symmetrical polyneuropathy (DSPN)Most common (75%); "stocking then glove" distribution; stocking firstBurning, tingling, numbness; worse at night; loss of protective sensation
Autonomic neuropathyAffects autonomic nervous systemGastroparesis, postural hypotension, erectile dysfunction, bladder dysfunction, gustatory sweating
MononeuropathySingle nerve; often vascular (ischaemia of vasa nervorum)CN III palsy (ptosis + diplopia + pupil SPARING); carpal tunnel; meralgia paraesthetica
Radiculopathy/plexopathyNerve root or plexus involvementLancinating pain in dermatomal distribution
Acute painful neuropathyAfter rapid glycaemic changeSevere burning pain; often transient

Neuropathy Assessment Tools

ToolTestsInterpretation
10g MonofilamentSemmes-Weinstein 10g monofilament applied to 10 plantar sitesUnable to detect monofilament = loss of protective sensation = HIGH ULCER RISK
128 Hz Tuning ForkVibration at hallux; if not felt, move up the limbLoss of vibration = earliest sign of large fibre neuropathy
Ankle reflexesAchilles tendon reflexAbsent reflex = neuropathy (sensitive early sign)
Temperature sensationCool vs warm stimulusLoss = small fibre neuropathy
NCS (Nerve Conduction Studies)ElectrophysiologyGOLD STANDARD for diagnosis and classification
Annual diabetic foot screening should include: monofilament test + tuning fork + ankle reflexes + visual inspection + ABI (ankle brachial index). Every diabetic patient should have a documented foot risk category.

Diabetic Foot Risk Classification

Risk CategoryFeaturesReview Frequency
Low riskNormal sensation, normal perfusion, no deformityAnnual
Moderate riskNeuropathy OR PAD OR deformityEvery 3–6 months
High riskNeuropathy + PAD or deformity; previous ulcerEvery 1–3 months
Active foot problemUlceration, gangrene, or active CharcotImmediate referral to multidisciplinary foot team

Glycaemic Optimisation — Primary Prevention

  • Intensive glycaemic control (HbA1c <53 mmol/mol / <7%) reduces neuropathy progression in T1DM (DCCT trial) and T2DM (UKPDS)
  • However, in established neuropathy, tight control has less impact — prevention is better than treatment
  • Address modifiable risk factors: smoking cessation, blood pressure control (<130/80), lipid management
  • Aldose reductase inhibitors — limited clinical benefit; not standard therapy

Pharmacological Pain Management

DrugDoseNotes
Pregabalin (first-line)75–300mg BDα2δ calcium channel ligand; faster titration than gabapentin; sedation, weight gain, dizziness
Duloxetine (first-line)60–120mg dailySNRI; also indicated for depression and fibromyalgia; nausea on initiation
Amitriptyline (first-line)10–75mg nocteTCA; sedating — useful if sleep disruption from nocturnal pain; anticholinergic side effects
Gabapentin300–1200mg TDSSimilar to pregabalin but slower titration; controlled drug in UK
Tramadol50–100mg QDSWeak opioid; second-line; dependence risk
Capsaicin cream/patch0.025–0.075% cream; 8% patchTopical; depletes substance P; burning sensation on application initially

Diabetic Foot Care — CRITICAL Nursing Interventions

Foot care education is one of the most important nursing interventions in diabetic neuropathy. A single missed foot inspection can lead to ulceration, infection, osteomyelitis, and amputation.
  • Daily foot inspection — patient self-inspection; use mirror for sole; carer inspection if vision impaired
  • Emollient application daily — prevent dry cracked skin (NOT between toes — fungal risk)
  • Appropriate footwear — padded, well-fitting, no pressure points; custom orthotics for deformity
  • NO barefoot walking — ever (home or outdoors)
  • Nail care: file rather than cut; podiatrist for nail care (patient must NOT self-cut thick/deformed nails)
  • Check temperature of bath water with elbow (not foot) — prevent burns to insensate skin
  • Never use hot water bottles or heating pads on feet
  • Any new blister, ulcer, redness, or wound = seek medical attention same day

Charcot Arthropathy (Charcot Neuroarthropathy)

Charcot arthropathy = painless progressive joint destruction in an insensate foot. The foot appears warm, red, and swollen — often initially misdiagnosed as cellulitis or DVT. NO trauma is recalled.
  • Mechanism: repeated micro-trauma to insensate joints → bony destruction and remodelling → joint collapse (rocker-bottom foot deformity)
  • Midfoot most commonly affected
  • Acute Charcot: warm, swollen, erythematous foot; skin intact; often no pain despite dramatic appearance
  • Distinguish from osteomyelitis: MRI ± bone biopsy if uncertain
  • Treatment: total contact casting (TCC) — off-loads the foot completely; non-weight-bearing; serial casting for months
  • Do NOT elevate Charcot foot (this reduces blood flow needed for healing)
  • Bisphosphonates (pamidronate) — may reduce activity in acute Charcot; limited evidence

Autonomic Neuropathy Complications

ManifestationSymptomsManagement
GastroparesisNausea, vomiting, early satiety, bloating, erratic glucose controlSmall frequent meals; prokinetics (metoclopramide, domperidone, erythromycin); avoid high-fat meals
Postural hypotensionDizziness, syncope on standing; BP drop ≥20/10 mmHg on standingGradual position changes; compression stockings; fludrocortisone; midodrine
Erectile dysfunctionImpotence; often earliest autonomic symptom in malesPDE5 inhibitors (sildenafil); vacuum device; prosthesis
Bladder dysfunctionUrinary retention, overflow incontinence, recurrent UTIsTimed voiding; intermittent catheterisation; treat UTIs promptly
Gustatory sweatingProfuse sweating over face/neck when eatingReassure; anticholinergics; botulinum toxin

Diabetic Neuropathy in the GCC

GCC countries have some of the world's highest T2DM prevalence rates (UAE 20–25%, Saudi Arabia 20%+). With the largest diabetic populations in the region, diabetic neuropathy is extremely common. Foot complications are a major cause of hospitalisation and amputation in GCC hospitals.
  • Late diagnosis of T2DM is common — patients often have neuropathy at diagnosis
  • Suboptimal glycaemic control (HbA1c >9% common in GCC populations) accelerates neuropathy progression
  • Multidisciplinary diabetic foot clinics established in major hospitals — DHA, MOH, SEHA

Cultural and Environmental Risk Factors in GCC

GCC-specific factors significantly increase foot complication risk in diabetic neuropathy patients:
  • Mosques: Muslims remove footwear before prayer — insensate feet on hard surfaces multiple times daily; footwear must be readily available immediately after prayer
  • Sandals: traditional sandal/flip-flop use exposes toes and soles to injury, pebbles, and heat
  • Desert heat: hot surfaces (sand, pavement) can burn insensate feet in minutes; maximum temperature of paved surfaces can exceed 70°C in UAE summer
  • Wading in water: sea and pool activities without footwear — lacerations not noticed
  • Nurses should specifically address these risks in foot care education, with culturally appropriate solutions (thin-soled mosque socks, appropriate beach footwear)

Diabetic Foot Services in GCC

  • Dubai Diabetes Centre — specialised multidisciplinary diabetic foot team including podiatrist, diabetologist, vascular surgeon, orthopaedic surgeon, nurse specialist
  • DHA and DOH diabetic foot pathways based on IWGDF (International Working Group on the Diabetic Foot) guidelines
  • Podiatry services expanding — previously limited; UK/Australian-trained podiatrists common in GCC private sector
  • Total contact casting available in specialist centres; vacuum-assisted closure (VAC) therapy for complex wounds

High-Yield Exam Points

  • 50% of diabetics develop neuropathy after 10 years
  • Most common type = distal symmetrical polyneuropathy (DSPN) — "stocking then glove"; stocking distribution FIRST
  • Autonomic neuropathy: gastroparesis, postural hypotension, erectile dysfunction
  • CN III mononeuropathy: ptosis + diplopia + pupil SPARING (vascular cause; external sphincter preserved)
  • Assessment: 10g monofilament + 128Hz tuning fork
  • NCS = gold standard for diagnosis
  • Pain treatment first-line: pregabalin OR duloxetine (both first-line); also amitriptyline
  • Foot care = CRITICAL: daily inspection, emollient, no barefoot, appropriate footwear, podiatry for nails
  • Charcot arthropathy = painless joint destruction; warm swollen foot; NO trauma; total contact casting
  • Distinguish Charcot from osteomyelitis: MRI ± biopsy

Common Exam Traps

  • CN III palsy in diabetes = PUPIL SPARING (vascular infarction spares outer pupillomotor fibres). Pupil-involving CN III = surgical emergency (posterior communicating artery aneurysm)
  • Charcot foot looks like cellulitis/infection but is NOT infected — skin is intact; no fever; no pus
  • DO NOT elevate a Charcot foot — reduces healing blood flow; treat with offloading and total contact cast
  • Vibration sense (tuning fork) is the EARLIEST large fibre sign to disappear — test at great toe first
GCC Clinical Practice Insights
Mosque Foot Care Advice for GCC Diabetic Patients +
Muslims pray five times daily and remove footwear before entering mosques. For diabetic patients with neuropathy, this creates significant risk: hard marble/tile floors, other people's footwear, and prolonged standing. Advice: wear clean white cotton socks for prayer (permissible in many Islamic schools of thought to wipe over socks for wudu), inspect feet immediately after prayer, and wear shoes with thin soles inside the mosque if the mosque allows. Document this in patient education records.
Hot Surface Burns in GCC Summer — Insensate Feet +
During UAE and Saudi summer (June–September), pavement and sand surface temperatures can exceed 60–70°C. A patient with insensate feet may stand on or walk across these surfaces without feeling pain, sustaining full-thickness burns. These burns are painless, often unnoticed for hours, and frequently present as non-healing wounds requiring hospitalisation. Education: NEVER go barefoot outdoors in summer; check footwear temperature before putting on; use UV-protective, padded sandals.
Ramadan and Diabetic Neuropathy Pain Management +
Patients with painful diabetic neuropathy who fast during Ramadan may need their medication schedules adjusted. Pregabalin and amitriptyline can often be taken at suhoor and iftar. Duloxetine daily dosing is flexible. Topical treatments (capsaicin cream) remain fully compatible with fasting. Nurses should proactively counsel patients on adapting medication timing and ensuring continued pain management during the fasting month.
Pregabalin Prescribing and Misuse in GCC +
Pregabalin has been subject to misuse and diversion in some GCC populations. DHA and Saudi MOH have implemented stricter prescribing controls. Nurses should be aware that patients requesting dose escalation beyond therapeutic ranges or multiple early prescription requests may warrant further clinical assessment. In the UK (from 2019), pregabalin is a Schedule 3 controlled drug — this awareness informs GCC nursing practice standards.
Practice MCQs

Q1. A 55-year-old diabetic man develops sudden right-sided ptosis (drooping eyelid) and diplopia. The right pupil size is EQUAL to the left. What is the most likely diagnosis?

Correct answer: C — Diabetic CN III palsy is PUPIL-SPARING because the vascular infarction of the vasa nervorum affects the central motor fibres but spares the outer pupillomotor (parasympathetic) fibres. This is the classic distinguishing feature. A PComm aneurysm compresses CN III externally — affects pupillomotor fibres FIRST, causing a dilated fixed pupil. Pupil involvement in CN III palsy = neurosurgical emergency.

Q2. During annual diabetic foot screening, a patient cannot feel the 10g Semmes-Weinstein monofilament at any of the 10 plantar sites. What does this indicate?

Correct answer: A — Loss of 10g monofilament sensation indicates loss of protective sensation — the patient cannot feel sufficient pressure to protect the foot from ulceration. This places the patient in the HIGH RISK foot category. Immediate actions: intensified foot care education (daily inspection, appropriate footwear, no barefoot), increase review to every 1–3 months, refer to podiatry, and arrange vascular assessment if any signs of PAD.

Q3. A diabetic patient presents with a warm, red, painless, swollen right foot. There is no visible wound or ulcer. X-ray shows bony fragmentation of the midfoot joints. What is the diagnosis?

Correct answer: C — Classic Charcot arthropathy: painless swollen warm red foot + bony destruction on X-ray in a patient with diabetic neuropathy. Absence of pain despite dramatic appearance = loss of protective sensation. No wound excludes active infection as the primary diagnosis. Treatment: total contact casting, absolute non-weight-bearing. Do NOT elevate the limb. MRI ± bone biopsy if osteomyelitis cannot be excluded.

Q4. A diabetic patient with painful neuropathy asks which drug is recommended as first-line treatment. Which answer is correct?

Correct answer: C — Pregabalin (α2δ calcium channel ligand) and duloxetine (SNRI) are both NICE and international guideline first-line treatments for painful diabetic neuropathy. Amitriptyline is also first-line. NSAIDs have no efficacy in neuropathic pain. Opioids are second or third-line. Vitamin B12 treats B12 deficiency neuropathy — not standard treatment for diabetic neuropathy unless B12-deficient.